By Reuters Dec 29, 2020 8:11:57 PM IST (Published)
Follow real-time updates on Union Budget 2023Catch exclusive videos on Union Budget 2023 from CNBC-TV18
The European Medicines Authority (EMA) will most likely not be able to approve the COVID-19 vaccine developed by drug maker AstraZeneca and the University of Oxford in January, the watchdog's Deputy Executive Director Noel Wathion said.
The European Medicines Authority (EMA) will most likely not be able to approve the COVID-19 vaccine developed by drug maker AstraZeneca and the University of Oxford in January, the watchdog's Deputy Executive Director Noel Wathion said.
Recommended Articles
View All
Budget 2023: Taking a bold step to unlock India’s potential
Feb 2, 2023 IST2 Min(s) Read
Budget 2023: Moving closer towards universal health through proper implementation is key
Feb 2, 2023 IST3 Min(s) Read
Explained: Pakistan economy on the edge of collapse — why India may be worried
Feb 2, 2023 IST10 Min(s) Read
Budget 2023: Unleashing India’s growth potential in the years to come
Feb 2, 2023 IST2 Min(s) Read
"They have not even filed an application with us yet", Wathion said in an interview with Belgian newspaper Het Nieuwsblad published on Tuesday.
European regulators have only received some information about the vaccine, Wathion said.
"Not even enough to warrant a conditional marketing licence", he said. "We need additional data about the quality of the vaccine. And after that, the company has to formally apply."
This made it "improbable" that an approval could already be granted next month, Wathion said.
The EMA could not be reached for comment.
AstraZeneca told Reuters last week that its COVID-19 vaccine should be effective against the new coronavirus variant, adding that studies were under way to fully probe the impact of the mutation.
It has submitted a full data package about its vaccine to the British medicines regulator, British health minister Matt Hancock said.
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!